Status: Recruiting
EVOLUTION® Revision STEMMED CS Post Market Clinical Follow-up Study Protocol
MicroPort (MPO) is conducting this PMCF study to evaluate the safety and effectiveness of its EVOLUTION® Revision Tibial System and EVOLUTION® Revision STEMMED CS Femur with the EVOLUTION® MP CS Tibial Insert. This type of study is required by regulatory authorities for all devices that have been approved in Europe to evaluate the medium and long-term clinical evidence.
Participants needed: 45
Trial details
Age: 21+Biological sex: AllType: ObservationalSponsor: MicroPort Orthopedics Inc.Updated: Jan 22, 2024Locations: 1
Eligibility criteria
Has previously undergone or currently has been determined to undergo a revision... [+4]
Skeletally immature (less than 21 years of age) at time of implantation [+7]